From both the parental B16F10 tumor mice and B16F10-Ova mice with no vaccine boost, we were unable to expand a sufficient number of viable CD8+ cells for use in screening, indicating that these mice were not mounting a detectable T-cell response to tumor antigen. Here, CD8A is linked to neoplasm.